Patents Assigned to Medessence Lifesciences (Suzhou), Inc.
  • Publication number: 20240138791
    Abstract: The present invention provides a train-like pharmaceutical composition (configuration, or dosage form) comprising segments linearly arranged in series like cars of a train. When the pharmaceutical composition is administrated into a patient's body, some of the segments are “visible” to an instrument, but others are not. However, “invisible” segments can be estimated, deduced, calculated, or inferred from “visible” segments. The “invisible” segments can be used for neutralizing intratumoral lactic acidosis combined with glucose deprivation to control tumor, among other applications.
    Type: Application
    Filed: December 15, 2023
    Publication date: May 2, 2024
    Applicant: Medessence Lifesciences (Suzhou), Inc.
    Inventors: Yonghua Dong, Rui Dong
  • Publication number: 20200281551
    Abstract: The present invention provides a train-like pharmaceutical composition (configuration, or dosage form) comprising segments linearly arranged in series like cars of a train. When the pharmaceutical composition is administrated into a patient's body, some of the segments are “visible” to an instrument, but others are not. However, “invisible” segments can be estimated, deduced, calculated, or inferred from “visible” segments. The “invisible” segments can be used for neutralizing intratumoral lactic acidosis combined with glucose deprivation to control tumor, among other applications.
    Type: Application
    Filed: May 23, 2020
    Publication date: September 10, 2020
    Applicant: Medessence Lifesciences (Suzhou), Inc.
    Inventors: Yonghua Dong, Rui Dong
  • Patent number: 10695018
    Abstract: The present invention provides a train-like pharmaceutical composition (configuration, or dosage form) comprising segments linearly arranged in series like cars of a train. When the pharmaceutical composition is administrated into a patient's body, some of the segments are “visible” to an instrument, but others are not. However, “invisible” segments can be estimated, deduced, calculated, or inferred from “visible” segments. The “invisible” segments can be used for neutralizing intratumoral lactic acidosis combined with glucose deprivation to control tumor, among other applications.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: June 30, 2020
    Assignee: Medessence Lifesciences (Suzhou), Inc.
    Inventors: Yonghua Dong, Rui Dong